Stockreport

Clene to Provide CNM-Au8® ALS Program Update

Clene Inc.  (CLNN) 
PDF SALT LAKE CITY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine I [Read more]